“Southern Africa must be innovative to tackle access to HIV and TB treatment” says ARASA
The right to life is being denied due to high prices for medicines. Addressing pharmaceuticals’ abuse of intellectual property law...
World AIDS Day 2017: Argentina remains without an effective HIV and hepatitis law
It’s perceived, that due to the lack of political will of the national government and a lack of interest from...
New Study: Assessment of national intellectual property landscapes and their impact on access to medicines (Egypt, Morocco, Tunisia)
ITPC-MENA has released a comparative study of intellectual property provisions in Tunisia, Morocco and Egypt. The study was undertaken to...
HIV activists trained on intellectual property and access to medicines
Demystifying intellectual property (IP) and providing advocacy tools. The International Treatment Preparedness Coalition – MENA (ITPC-MENA) with the support...
Myanmar: Creating an intellectual property law that protects public health
Lobbying for an intellectual property law that doesn’t just serve big business, but protects public health and encourages innovation in...
Online access: Training course on reducing barriers to medicines in Africa
Making intellectual property issues easier to understand, to increase access to medicines – and you can apply now! An online...
A victory for ITPC-MENA : Bristol-Myers Squibb extends its voluntary license on atazanavir to Egypt
During the 9th International AIDS Conference (23-26 July 2017), Bristol-Myers Squibb (BMS) and the Medicines Patent Pool (MPP) announced the...
Patients and Ministers discuss access to essential medicines in Ukraine
Working together to reform patent law in Ukraine – and new Working Group is founded. Last month (21 April) our...
Brazilian Activists: Third-party in a legal case, to prevent weakening of patent system
On April 7, the Working Group on Intellectual Property of the Brazilian Network for the Integration of Peoples (GTPI/Rebrip), filed...
Open Letter to WHO Director General, Margaret Chan
Civil Society Open Letter urging WHO to include UN High Level Panel on Access to Medicines Report on WHO Board Agenda